Porton to Showcase Integrated CDMO Expertise at BOS Basel 2025

BOS Basel 2025, a premier global event for biopharmaceutical outsourcing, will convene industry leaders to address critical challenges in CMC outsourcing for Small Molecules, Biologics, and Novel Therapeutic Entities. Since its inception in Sheffield (2006), BOS Events have evolved into a refined platform featuring four key components, including a dynamic exhibition highlighting innovations from CROs and CMOs worldwide. （Note: Information sourced from the BOS official website.)

Porton Pharma Solutions, a global CDMO with over 4,200 employees and GMP facilities across the US, EU, and China, will demonstrate its end-to-end capabilities in Small Molecules, Tides, Biologics, Conjugates (ADCs, AOCs, PDCs, etc.), and Advanced Therapy Medicinal Products (ATMPs) at Booth #62. Our customer-centric solutions span preclinical development to commercial manufacturing, supported by state-of-the-art technology platforms and proven expertise in complex modalities. 

Engaging with our scientists and business leaders at Booth #62 to share the latest industry insights and discuss future challenges. Schedule a personalized meeting via our website to explore how we can accelerate your program’s success.